MYGN

#2997
Myriad Genetics Inc
4.9100 USD
+6.97%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
4.9100
4.9100
年范围
4.1050
8.5000
日变化
+6.97%
每月变动
+5.36%
6个月变化
-40.63%
年变化
-40.63%
前一天收盘价
4.5900
开盘价
4.9100
买价
卖价
最低价
4.9100
High
4.9100
交易量
129
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 459.1251 M
  • Employee 2 700
  • Founded 1991
  • CEO Paul J. DiazPaul J. Diaz
  • Website www.myriad.com
  • Headquarter Delaware, United States
  • FIGI BBG000D9H9F1
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-1.56
市销率
0.69

Myriad Genetics Inc

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

新闻